oai:pubmedcentral.nih.gov:9275...
Taylor & Francis
Bioengineered
2022
11/28/2023
Previous studies manifested that microRNA-145-5p is pivotal in the development of various cancers.
Nevertheless, the potential function of microRNA-145-5p in colorectal cancer remains unclear.
This study attempted to investigate the potential role and possible mechanism of microRNA-145-5p in colon cancer.
MicroRNA-145-5p and phosphoserine aminotransferase 1 (PSAT1) levels in colon cancer cells were assayed via quantitative reverse transcription polymerase chain reaction (qRT-PCR).
Cell proliferation and cell cycle status were assessed using Cell Counting Kit-8, colony formation, and flow cytometry.
The target binding relationship of microRNA-145-5p and PSAT1 was identified using bioinformatics analysis and dual-luciferase reporter gene assay.
The result of qRT-PCR disclosed that microRNA-145-5p was markedly down-regulated and PSAT1 level was up-regulated in colon cancer cell lines.
Besides, enforced microRNA-145-5p level repressed proliferation of colon cancer cells, and cells were arrested in G0-G1 phase.
Bioinformatics analysis and dual-luciferase reporter genes confirmed that PSAT1 was a downstream target of microRNA-145-5p.
Enforced PSAT1 level remarkably modulated cell cycle and fostered cell proliferation.
Furthermore, rescue experiments displayed that microRNA-145-5p restrained cell cycle progression and cell proliferation and forced PSAT1 level could partially reverse this process.
Taken together, our findings demonstrated that microRNA-145-5p repressed colon cancer cell cycle progression and cell proliferation via targeting PSAT1.
Our findings identified microRNA-145-5p as an essential tumor repressor gene in colon cancer and may provide a novel biomarker for colon cancer.
Ding, Ruliang,Hong, Weiwen,Huang, Liang,Shao, Jinfan,Yu, Wenfeng,Xu, Xijuan, 2022, Examination of the effects of microRNA-145-5p and phosphoserine aminotransferase 1 in colon cancer, Taylor & Francis